FHTX Average Annual Return Since 2020
FHTX Average Annual Return Chart Since 2020
Growth of $10,000.00
Without Dividends Reinvested Into FHTX

Also see:
• FHTX stock yearly return 2021
• FHTX stock yearly return 2022
• FHTX stock yearly return 2023
• FHTX stock yearly return 2024
• FHTX stock yearly return 2025
• FHTX YTD return
Average Annual Return Benchmarks
Compare FHTX average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
FHTX Share Performance
FHTX Average Annual Return Table Since 2020
Start date: 10/26/2020
End date: 04/17/2026
Start price/share: $17.20
End price/share: $5.29
Dividends collected/share: $0.00
Total return: -69.24%
FHTX Average Annual Return: -19.37%
Starting investment: $10,000.00
Ending investment: $3,075.45
Years: 5.48


FHTX average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Foghorn Therapeutics Inc
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company engaged in developing medicines that modulate gene expression through selectively targeting the chromatin regulatory system for therapeutic intervention in oncology. Its Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within the system. Co.'s Traffic Control platform discovers and develops drugs in oncology and other therapeutic areas, including virology, autoimmune disease and neurology. The FHTX average annual return since 2020 is shown above.

The Average Annual Return on the FHTX average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether FHTX average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the FHTX average annual return calculation with any dividends reinvested as applicable (on ex-dates).
FHTX Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree FHTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Foghorn Therapeutics (FHTX) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

FLGT Average Annual Return
FLXN Average Annual Return
FOLD Average Annual Return
FONR Average Annual Return
FRMM Average Annual Return
FTRE Average Annual Return
FULC Average Annual Return
GALT Average Annual Return
GANX Average Annual Return
GCTK Average Annual Return
More Healthcare companies »
 

FHTX Average Annual Return Since 2020 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.